Evolus soars after Q4 revenue jump
** Shares of beauty company Evolus EOLS.O climb 30.8% to $5.4 after Q4 revenue jumps 14.4% ** Stock on track for biggest intraday percentage gain in nearly five years ** Co reports revenue of $90.3 million, compared with $78.9 million a year earlier ** EOLS says it saw sales growth across products ** Stock has plunged 38% YTD as of last close (Reporting by Niket Nishant) ((Niket.Nishant@thomsonreuters.com))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe